Beta Bionics (BBNX) Assets Average (2025 - 2026)
Beta Bionics (BBNX) posted Assets Average of $298.4 million for Q2 2026, down 5.74% sequentially from $316.6 million in Q1 2026, and down 10.66% YoY from $334.0 million in Q2 2025.
Beta Bionics (BBNX) Assets Average (2025 - 2026) Analysis & Trends
Beta Bionics has reported Assets Average for 2 years, with the latest figure at $298.4 million in Q2 2026.
- Quarterly Assets Average fell 10.66% year-over-year to $298.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $298.4 million (down 10.66% YoY) and the FY2025 annual result came in at $239.2 million, up 84.22% from the prior year.
- Assets Average slipped to $298.4 million in Q2 2026 per BBNX's latest filing, from $316.6 million in the prior quarter.
- Over five years, Assets Average peaked at $334.0 million in Q2 2025 and troughed at $243.8 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 109.82 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 47.11 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 92.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 44.78 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 13.59 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 6.54 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 37.19 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 31.48 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Beta Bionics | 865.29 Mn | 684.80 Mn | 18.90 Mn | 298.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 298.40 Mn |
| Mar 31, 2026 | 316.58 Mn |
| Dec 31, 2025 | 329.39 Mn |
| Sep 30, 2025 | 330.01 Mn |
| Jun 30, 2025 | 334.00 Mn |
| Mar 31, 2025 | 243.83 Mn |